| # | Title | Journal | Year | Citations |
|---|
| 1 | Association analysis identifies 65 new breast cancer risk loci | Nature | 2017 | 1,099 |
| 2 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | American Journal of Human Genetics | 2019 | 711 |
| 3 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair | Nature Genetics | 2015 | 357 |
| 4 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | Nature Genetics | 2017 | 289 |
| 5 | Patients and staff as codesigners of healthcare services | BMJ, The | 2015 | 277 |
| 6 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses | Nature Genetics | 2020 | 265 |
| 7 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer | Nature Genetics | 2018 | 184 |
| 8 | Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis | Breast Cancer Research | 2011 | 165 |
| 9 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types | Cancer Discovery | 2016 | 157 |
| 10 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes | Nature Genetics | 2020 | 120 |
| 11 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent | PLoS Medicine | 2016 | 118 |
| 12 | Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation | Modern Pathology | 2010 | 90 |
| 13 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer | Nature Communications | 2019 | 90 |
| 14 | Shared heritability and functional enrichment across six solid cancers | Nature Communications | 2019 | 88 |
| 15 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus | Nature Communications | 2016 | 78 |
| 16 | Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE | Oncogene | 2016 | 76 |
| 17 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer | Cancer Research | 2017 | 75 |
| 18 | Germline CDH1 mutations in bilateral lobular carcinoma in situ | British Journal of Cancer | 2014 | 70 |
| 19 | Systematic review of high-intensity focused ultrasound ablation in the treatment of breast cancer | British Journal of Surgery | 2015 | 70 |
| 20 | Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer | Breast Cancer Research and Treatment | 2015 | 68 |
| 21 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk | Genetics in Medicine | 2017 | 67 |
| 22 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation | American Journal of Human Genetics | 2016 | 59 |
| 23 | Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer | British Journal of Cancer | 2013 | 52 |
| 24 | Genome-wide association study of germline variants and breast cancer-specific mortality | British Journal of Cancer | 2019 | 52 |
| 25 | Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer | International Journal of Cancer | 2016 | 51 |
| 26 | Body mass index and breast cancer survival: a Mendelian randomization analysis | International Journal of Epidemiology | 2017 | 45 |
| 27 | Genetic predisposition to ductal carcinoma in situ of the breast | Breast Cancer Research | 2016 | 43 |
| 28 | Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells | Stem Cell Reports | 2014 | 42 |
| 29 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk | American Journal of Human Genetics | 2020 | 39 |
| 30 | SOX11 promotes invasive growth and ductal carcinoma in situ progression | Journal of Pathology | 2017 | 36 |
| 31 | Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status | Genetic Epidemiology | 2020 | 32 |
| 32 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 | Oncotarget | 2016 | 31 |
| 33 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus | Breast Cancer Research | 2016 | 31 |
| 34 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis | Nature Communications | 2020 | 30 |
| 35 | Transforming growth factor‐β1 is constitutively secreted by chinese hamster ovary cells and is functional in human cells | Biotechnology and Bioengineering | 2011 | 29 |
| 36 | The treatment and survival of patients with triple negative breast cancer in a London population | SpringerPlus | 2014 | 27 |
| 37 | Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines | PLoS ONE | 2016 | 26 |
| 38 | RAD51B in Familial Breast Cancer | PLoS ONE | 2016 | 26 |
| 39 | Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk | Cancer Epidemiology Biomarkers and Prevention | 2015 | 24 |
| 40 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry | Cancer Causes and Control | 2016 | 21 |
| 41 | What can be done about hot flushes after treatment for breast cancer? | Climacteric | 2010 | 19 |
| 42 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) | Scientific Reports | 2016 | 19 |
| 43 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity | Human Mutation | 2018 | 19 |
| 44 | Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium | Cancer Epidemiology Biomarkers and Prevention | 2021 | 19 |
| 45 | Inhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness | Annals of Oncology | 2018 | 18 |
| 46 | The effect of emergency presentation on surgery and survival in lung cancer patients in England, 2006–2008 | Cancer Epidemiology | 2015 | 14 |
| 47 | Exploring a potential mechanistic role of DNA methylation in the relationship betweenin uteroand post‐natal environmental exposures and risk of childhood acute lymphoblastic leukaemia | International Journal of Cancer | 2019 | 13 |
| 48 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus | PLoS ONE | 2016 | 12 |
| 49 | PHIP- a novel candidate breast cancer susceptibility locus on 6q14.1 | Oncotarget | 2017 | 9 |
| 50 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium | Human Genetics | 2016 | 8 |
